A citation-based method for searching scientific literature

Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks, Christopher Kennard, Bernhard Landwehrmeyer, Julie C Stout, Beth Borowsky, Rachael I Scahill, Chris Frost, Douglas R Langbehn. Lancet Neurol 2012
Times Cited: 380







List of co-cited articles
862 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
679
47


Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
536
42

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks,[...]. Lancet Neurol 2011
404
34


Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
585
24

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
562
23

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
707
21

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
501
21

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
262
15

Longitudinal change in regional brain volumes in prodromal Huntington disease.
Elizabeth H Aylward, Peggy C Nopoulos, Christopher A Ross, Douglas R Langbehn, Ronald K Pierson, James A Mills, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Jane S Paulsen. J Neurol Neurosurg Psychiatry 2011
177
14

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington,[...]. Front Aging Neurosci 2014
140
14

Huntington's disease.
Francis O Walker. Lancet 2007
14

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
14

Indexing disease progression at study entry with individuals at-risk for Huntington disease.
Ying Zhang, Jeffrey D Long, James A Mills, John H Warner, Wenjing Lu, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2011
159
13

Striatal and white matter predictors of estimated diagnosis for Huntington disease.
Jane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, Christopher A Ross, Hans Johnson, Vincent A Magnotta, Andrew Juhl, Ronald K Pierson, James Mills, Douglas Langbehn,[...]. Brain Res Bull 2010
177
13

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
Lauren M Byrne, Filipe B Rodrigues, Eileanor B Johnson, Peter A Wijeratne, Enrico De Vita, Daniel C Alexander, Giuseppe Palermo, Christian Czech, Scott Schobel, Rachael I Scahill,[...]. Sci Transl Med 2018
81
16

Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
338
13

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden. Clin Genet 2004
562
12

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Juan F Domínguez D, Gary F Egan, Marcus A Gray, Govinda R Poudel, Andrew Churchyard, Phyllis Chua, Julie C Stout, Nellie Georgiou-Karistianis. PLoS One 2013
62
17

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.
Julie C Stout, Rebecca Jones, Izelle Labuschagne, Alison M O'Regan, Miranda J Say, Eve M Dumas, Sarah Queller, Damian Justo, Rachelle Dar Santos, Allison Coleman,[...]. J Neurol Neurosurg Psychiatry 2012
96
11

Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
Govinda R Poudel, Julie C Stout, Juan F Domínguez D, Andrew Churchyard, Phyllis Chua, Gary F Egan, Nellie Georgiou-Karistianis. Neurobiol Dis 2015
67
16

Onset and rate of striatal atrophy in preclinical Huntington disease.
E H Aylward, B F Sparks, K M Field, V Yallapragada, B D Shpritz, A Rosenblatt, J Brandt, L M Gourley, K Liang, H Zhou,[...]. Neurology 2004
291
10

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
10

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Jane S Paulsen, Jeffrey D Long, Christopher A Ross, Deborah L Harrington, Cheryl J Erwin, Janet K Williams, Holly James Westervelt, Hans J Johnson, Elizabeth H Aylward, Ying Zhang,[...]. Lancet Neurol 2014
160
10

Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
Andrea Ciarmiello, Milena Cannella, Secondo Lastoria, Maria Simonelli, Luigi Frati, David C Rubinsztein, Ferdinando Squitieri. J Nucl Med 2006
197
10

Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials.
Nellie Georgiou-Karistianis, Rachael Scahill, Sarah J Tabrizi, Ferdinando Squitieri, Elizabeth Aylward. Neurosci Biobehav Rev 2013
63
15

In vivo characterization of white matter pathology in premanifest huntington's disease.
Jiaying Zhang, Sarah Gregory, Rachael I Scahill, Alexandra Durr, David L Thomas, Stéphane Lehericy, Geraint Rees, Sarah J Tabrizi, Hui Zhang. Ann Neurol 2018
30
33

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
Edward J Wild, Roberto Boggio, Douglas Langbehn, Nicola Robertson, Salman Haider, James R C Miller, Henrik Zetterberg, Blair R Leavitt, Rainer Kuhn, Sarah J Tabrizi,[...]. J Clin Invest 2015
146
10

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L Cummings, Howard Chertkow. J Am Geriatr Soc 2005
9

Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington's Disease.
Izelle Labuschagne, Amy Mulick Cassidy, Rachael I Scahill, Eileanoir B Johnson, Elin Rees, Alison O'Regan, Sarah Queller, Chris Frost, Blair R Leavitt, Alexandra Dürr,[...]. J Int Neuropsychol Soc 2016
31
29

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study.
Stefan Klöppel, Sarah Gregory, Elisa Scheller, Lora Minkova, Adeel Razi, Alexandra Durr, Raymund A C Roos, Blair R Leavitt, Marina Papoutsi, G Bernhard Landwehrmeyer,[...]. EBioMedicine 2015
88
10

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Lauren M Byrne, Filipe B Rodrigues, Kaj Blennow, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Rachael I Scahill, Sarah J Tabrizi, Henrik Zetterberg, Douglas Langbehn,[...]. Lancet Neurol 2017
190
9

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
H Diana Rosas, David H Salat, Stephanie Y Lee, Alexandra K Zaleta, Vasanth Pappu, Bruce Fischl, Doug Greve, Nathanael Hevelone, Steven M Hersch. Brain 2008
330
9

Cerebral cortex structure in prodromal Huntington disease.
Peggy C Nopoulos, Elizabeth H Aylward, Christopher A Ross, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Ronald K Pierson, James Mills, Douglas R Langbehn, Jane S Paulsen. Neurobiol Dis 2010
101
8

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
H D Rosas, N D Hevelone, A K Zaleta, D N Greve, D H Salat, B Fischl. Neurology 2005
235
8

Advances in functional and structural MR image analysis and implementation as FSL.
Stephen M Smith, Mark Jenkinson, Mark W Woolrich, Christian F Beckmann, Timothy E J Behrens, Heidi Johansen-Berg, Peter R Bannister, Marilena De Luca, Ivana Drobnjak, David E Flitney,[...]. Neuroimage 2004
8

Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease.
Georg B Landwehrmeyer, Cheryl J Fitzer-Attas, Joseph D Giuliano, Nilza Gonçalves, Karen E Anderson, Francisco Cardoso, Joaquim J Ferreira, Tiago A Mestre, Julie C Stout, Cristina Sampaio. Mov Disord Clin Pract 2016
103
8

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.
Scott A Schobel, Giuseppe Palermo, Peggy Auinger, Jeffrey D Long, Shiyang Ma, Omar S Khwaja, Dylan Trundell, Merit Cudkowicz, Steven Hersch, Cristina Sampaio,[...]. Neurology 2017
66
12

Association of CAG Repeats With Long-term Progression in Huntington Disease.
Douglas R Langbehn, Julie C Stout, Sarah Gregory, James A Mills, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Jeffrey D Long, Gail Owen, Hans J Johnson,[...]. JAMA Neurol 2019
24
33

Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.
Peter McColgan, Sarah Gregory, Kiran K Seunarine, Adeel Razi, Marina Papoutsi, Eileanoir Johnson, Alexandra Durr, Raymund A C Roos, Blair R Leavitt, Peter Holmans,[...]. Biol Psychiatry 2018
49
16

Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
Rachael I Scahill, Paul Zeun, Katherine Osborne-Crowley, Eileanoir B Johnson, Sarah Gregory, Christopher Parker, Jessica Lowe, Akshay Nair, Claire O'Callaghan, Christelle Langley,[...]. Lancet Neurol 2020
66
12

Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications.
George Bartzokis, Po H Lu, Todd A Tishler, Sophia M Fong, Bolanle Oluwadara, J Paul Finn, Danny Huang, Yvette Bordelon, Jim Mintz, Susan Perlman. Neurochem Res 2007
164
7

Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease.
Roy Tang Yi Teo, Xin Hong, Libo Yu-Taeger, Yihui Huang, Liang Juin Tan, Yuanyun Xie, Xuan Vinh To, Ling Guo, Reshmi Rajendran, Arianna Novati,[...]. Hum Mol Genet 2016
46
15

Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.
Brenda Huang, WenJie Wei, Guohao Wang, Marta A Gaertig, Yue Feng, Wei Wang, Xiao-Jiang Li, Shihua Li. Neuron 2015
94
7

Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
Saul Martinez-Horta, Jesus Perez-Perez, Erik van Duijn, Ramon Fernandez-Bobadilla, Mar Carceller, Javier Pagonabarraga, Berta Pascual-Sedano, Antonia Campolongo, Jesus Ruiz-Idiago, Frederic Sampedro,[...]. Parkinsonism Relat Disord 2016
90
7

The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease.
Eileanoir B Johnson, Elin M Rees, Izelle Labuschagne, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Ralf Reilmann, Hans Johnson, Nicola Z Hobbs, Douglas R Langbehn,[...]. Neuropsychologia 2015
42
16

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.
Douglas R Langbehn, Michael R Hayden, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2010
231
7


White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Govinda R Poudel, Julie C Stout, Juan F Domínguez D, Louisa Salmon, Andrew Churchyard, Phyllis Chua, Nellie Georgiou-Karistianis, Gary F Egan. Neurobiol Dis 2014
67
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.